Ensuring a Path of Success for Drug Repurposing in PAH
January 14th 2021, 9:15pm
ArticleAmong the viewpoints offered by the authors to overcome barriers in solving unmet needs in pulmonary arterial hypertension (PAH) are preclinical pipelines for drug repurposing, working around challenges in early-stage trial design, and refining target selection and demonstration of engagement.